SCHEMBL20617401

SCHEMBL20617401

N#Cc1cc(-c2cc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccccc6)c5c43)c(C#N)cc2-n2c3ccccc3c3ccc4c5ccccc5n(-c5ccccc5)c4c32)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.36
▸ RXRG P48443 1/20 0.36
▸ PDPK1 O15530 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ XDH P47989 1/20 0.33
▸ PGR P06401 1/20 0.32
▸ TAS2R14 Q9NYV8 1/20 0.32
▸ KIF11 P52732 1/20 0.32
▸ AR P10275 1/20 0.32
▸ MAT2A P31153 1/20 0.32
▸ CTSK P43235 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ DRD3 P35462 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ METAP2 P50579 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22822544 0.94 RXRA (0.36) RXRARXRGPDPK1KDM4EATM
SCHEMBL20617402 0.92 RXRA (0.33) RXRARXRGPDPK1KDM4EATM
SCHEMBL21414216 0.91 KDM4E (0.39) KDM4EATML3MBTL1XDHPGR
SCHEMBL22822273 0.89 KIF11 (0.41) RXRARXRGPDPK1XDHTAS2R14
SCHEMBL22822130 0.87 RXRA (0.34) RXRARXRGPDPK1KDM4EXDH
SCHEMBL22822507 0.87 RXRA (0.34) RXRARXRGPDPK1KDM4EXDH
SCHEMBL22564390 0.87 KIF11 (0.41) RXRARXRGPDPK1KDM4EXDH
SCHEMBL22564568 0.87 RXRA (0.35) RXRARXRGPDPK1KDM4EXDH
SCHEMBL22564579 0.85 RXRA (0.38) RXRARXRGPDPK1KDM4EATM
SCHEMBL20617079 0.85 RXRA (0.40) RXRARXRGPDPK1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021473-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-06-01 — — US disclosed
US-20200399256-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-24 — — US disclosed
EP-3642302-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 — — EP disclosed
WO-2019001838-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021473-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OCIAD2 RXRA 3552/4885RXRG 3138/4885PDPK1 4315/4885
US-20200399256-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 RXRA 3876/4885RXRG 3543/4885PDPK1 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback